Register for free to listen to this article
Listen with Speechify
0:00
1:00
WAKEFIELD, Mass.—Eliassen Group's eClinical Solutions Division has signed a partnership agreement with Medidata Solutions, a provider of electronic clinical data capture (EDC), management and reporting solutions. As a member of Medidata's ASPire to Win program, Eliassen's eClinical Solutions Division will leverage its specialized clinical data management expertise to provide pharmaceutical, biotechnology and medical device companies with the ability to help maximize the benefits of Rave."Eliassen eClinical Solutions will be a valuable consulting service resource to Medidata customers who want to optimize Rave in their study environments and maximize their technology investment. Our team's significant hands-on experience in the set-up, deployment and execution of EDC for clinical trials enables us to support client requirements and deliver a robust clinical trial development process," says Susan Bornstein, EVP Eliassen Group eClinical Solutions.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue